Comparison of the efficacy of botulinum toxin and triamcinolone in patients with hypertrophic scars treated with PDL laser

Phase 2

Recruiting

• Conditions: Hypertrophic erythematous scar.; Hypertrophic scar; L91.0

• Registration Number: IRCT20220121053776N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Patients over 18 years
Patients with a confirmed diagnosis of hypertrophic erythematous scars of at least 3
The size of the mentioned lesions should be at least 10 × 10 cm or have a length of at least 10 cm
The patient is not pregnant or breast feeding
The patient has not received any treatment for lesions such as laser, topical or injectable corticosteroids in the past two months
The patient has no underlying diseases that lead to the healing process of the scar; Such as diabetes or weakened immune system
The patient's cooperation in performing medical interventions and referring to all treatment sessions

Exclusion Criteria

Occurrence of pregnancy during treatment or follow-up period
The occurrence of allergies or any side effects to one of the therapeutic interventions that prevent further treatment
Diagnosis of malignancy or systemic disease during treatment or follow-up period
The appearance of bacterial or viral skin diseases during treatment or follow-up

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effectiveness of treatment. Timepoint: Three months after the first treatment session. Method of measurement: By using Vancouver scar scale (VSS) scoring method.

Secondary Outcome Measures

Name	Time	Method
Safety. Timepoint: One, two and three months after the first treatment session. Method of measurement: Questions about possible side effects of treatment.;Tolerability. Timepoint: One, two and three months after the first treatment session. Method of measurement: Question from the patient.;Satisfaction. Timepoint: One, two and three months after the first treatment session. Method of measurement: Based on patient scoring.